XGN (STOCKS)
Exagen Inc. Common Stock
$3.340000
-0.160000 (-4.57%)
Prev close: $3.500000
Company Information
- Exchange
- XNAS
- Sector
- Health Services
- Industry
- Medical/Nursing Services
- CEO
- John Aballi
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $74.90M
- Employees
- 209
- P/E (TTM)
- -3.56
- P/B (TTM)
- 4.10
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
8
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-0.31 | $-0.16 | -0.1509 | -94.85% |
|
Jun 2025 (Q2)
|
$-0.18 | $-0.14 | -0.0363 | -25.98% |
|
Mar 2025 (Q1)
|
$-0.20 | $-0.20 | +0.0037 | +1.82% |
|
Dec 2024 (Q4)
|
$-0.20 | $-0.26 | +0.0626 | +23.84% |
Financial Statements
| Revenues | $63.60M |
| Benefits Costs and Expenses | $50.55M |
| Cost Of Revenue | $25.53M |
| Costs And Expenses | $50.55M |
| Gross Profit | $38.07M |
| Operating Expenses | $50.55M |
| Selling, General, and Administrative Expenses | $44.40M |
| Research and Development | $6.15M |
| Operating Income/Loss | -$12.48M |
| Income/Loss From Continuing Operations After Tax | -$19.04M |
| Income/Loss From Continuing Operations Before Tax | -$2.33M |
| Income Tax Expense/Benefit | $50.00K |
| Net Income/Loss | -$19.04M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$19.04M |
| Net Income/Loss Available To Common Stockholders, Basic | -$19.04M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.93 |
| Diluted Earnings Per Share | -$0.93 |
| Basic Average Shares | 20,953,868 |
| Diluted Average Shares | 20,953,868 |
| Assets | $62.82M |
| Current Assets | $52.59M |
| Noncurrent Assets | $10.23M |
| Liabilities | $44.69M |
| Current Liabilities | $12.89M |
| Accounts Payable | $3.56M |
| Other Current Liabilities | $9.33M |
| Noncurrent Liabilities | $31.80M |
| Long-term Debt | $22.94M |
| Other Non-current Liabilities | $8.85M |
| Equity | $18.14M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $18.14M |
| Liabilities And Equity | $62.82M |
| Net Cash Flow From Operating Activities | -$10.25M |
| Net Cash Flow From Operating Activities, Continuing | -$10.25M |
| Net Cash Flow From Investing Activities | -$737.00K |
| Net Cash Flow From Investing Activities, Continuing | -$737.00K |
| Net Cash Flow From Financing Activities | $24.60M |
| Net Cash Flow From Financing Activities, Continuing | $24.60M |
| Net Cash Flow | $13.62M |
| Net Cash Flow, Continuing | $13.62M |
| Comprehensive Income/Loss | -$19.04M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$19.04M |
| Other Comprehensive Income/Loss | $0.00 |